← Leaderboards
Michael Anthony Tones
Pulse Therapeutics, Inc.
$804,988
Attributed
$1,179,120
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $748.3K · FY2016–21$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,179,120 · 2
By mechanism
R44$748,265 · 1
R43$430,855 · 1
Top collaborators
- Colin Pieter Derdeyn1 shared
Most similar at Pulse Therapeutics, Inc.
Same institution · by research overlap
- Francis Milton Creighton$7,398,011
- Richard Gordon Bach$583,627
- William James Harrison$513,475
- Martin Omid Akhavan$530,790
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventPharmaceutical PreparationsStandard Of CareTechnologyDoseIn VitroNovel TherapeuticsSmall Business Innovation Research GrantBaseCessation Of LifeAlteplaseBiological AvailabilityBiological SciencesBiomaterial CompatibilityBiochemicalAlgorithmsAcuteCerebral ArteryCaringCapital FinancingAutomobile DrivingAlgorithmic SoftwareCitric Acid CycleBrain Tissue